Achieve Life Sciences, Inc. (ACHV)

NASDAQ: ACHV · USD

$6.83

-0.10 (-1.4%)· Recorded snapshot

Market cap	702.8M
Net income (ttm)	-114M
EPS (ttm)	-$1.81
Shares out	102.9M
Volume	803,317
Beta	2.31

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -114M
EPS (ttm): -$1.81
Market cap: 702.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	보유

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-845

P25 -113.8P50 -46.5P75 -0.9

ROIC-140.4

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All ACHV indicators

Market & fundamental data

Available fields

178

Groups with data

Currency

USD

Showing 178 of 178 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000949858
Company name	Achieve Life Sciences, Inc.
Country	United States
Country code	US
CUSIP number	004468500
Earnings date	2026-11-09
Earnings time	bmo
Employees	28
Employees change	3
Employees growth	12%
Enterprise value	$530.5M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
In index	RUSSELL2000
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US0044685008
Last 10-K release date	2026-03-24
Last earnings date	2026-08-11
Last refreshed	2026-10-28
Last stock split date	2020-07-31
Last stock split type	Reverse
Market cap	$702.8M
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$6.83
Price currency	USD
Sector	Healthcare
SIC code	2835
Stock price date	2026-10-28
Symbol	ACHV
U.S. state	Washington
Website	https://www.achievelifesciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-26.49%
FCF / EV yield	-9.08%
FCF yield	-6.81%
Forward EV/Sales	74.31x
Forward P/S	99.03x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	$-4.1M
ROA	-29.21%
ROA (5Y)	-70.29%
ROCE	807.4%
ROE	-844.99%
ROE (5Y)	-374.32%
ROIC	-140.36%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-19,000
Depreciation and amortization	$225,000
EBIT	$-58.3M
EBITDA	$-58.1M
EPS	$-1.81
FCF per share	$-0.46
Financing cash flow	$178.8M
Free cash flow	$-47M
Free cash flow minus SBC	$-56.9M
Investing cash flow	$-135.5M
Net borrowing	$5M
Net cash flow	$-3.7M
Net income	$-114M
Operating cash flow minus SBC	$-56.9M
Operating income	$-58.3M
Stock-based compensation	$9.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$-0.14
Goodwill	$1M
Interest coverage	-58.63
Long-term assets	$2.1M
Long-term liabilities	$7.5M
Net cash (debt)	$172.4M
Net cash / market cap	24.96%
Net cash growth	279.33%
Piotroski F-Score	2
Property, plant and equipment	$34,000
Shareholders' equity	$-14.7M
Tangible book value	$-16.5M
Tangible book value per share	$-0.16
Total assets	$190.4M
Total cash	$187.3M
Total debt	$14.9M
Total liabilities	$205.1M
WACC	16.7%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$188.3M
Current liabilities	$197.7M
Current ratio	0.95
Net working capital	$-189.2M
Quick ratio	0.95
Working capital	$-9.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-82.32%
Dividend yield	0%
Shareholder yield	-82.32%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$6.02
1D price change	-1.44%
1M price change	-10.88%
1M total return	-10.88%
1W price change	3.23%
1W total return	3.23%
1Y price change	43.59%
1Y return CAGR	43.63%
1Y total return	43.59%
20-day SMA	$6.89
200-day SMA	$5.63
3M price change	8.74%
3M total return	8.74%
3Y price change	71.43%
3Y return CAGR	19.68%
3Y total return	71.43%
50-day SMA	$7.50
50-day SMA vs 200-day SMA	50over200
52-week high	$8.64
52-week high date	2026-09-03
52-week low	$2.62
52-week low date	2026-03-30
5Y price change	-17.04%
5Y return CAGR	-3.67%
5Y total return	-17.04%
6M price change	69.7%
6M total return	69.7%
All-time high	$1,053.69
All-time high date	2017-08-02
All-time low	$1.84
All-time low date	2025-04-09
Average true range (ATR)	$0.38
Average volume	1.3M
Beta (1Y)	4.1
Beta (2Y)	2.64
Beta (5Y)	2.31
Change from 52-week high	-20.95%
Change from 52-week low	160.69%
Change from all-time high	-99.36%
Change from all-time low	265.22%
Change from open	-0.44%
Day's gap	-1.01%
Dollar volume	$5.5M
High price	$6.96
Low price	$6.68
Monthly RSI	54.69
Open price	$6.86
Position in 52-week range	53.57%
Premarket change	-0.43%
Premarket close	$6.93
Premarket price	$6.90
Premarket volume	1.2K
Previous close	$6.93
Price vs 150-day SMA	11.68%
Price vs 20-day SMA	-2.51%
Price vs 200-day SMA	19.45%
Price vs 50-day SMA	-10.4%
Relative volume	0.62
RSI	43.84
Sharpe ratio	0.8
Sharpe ratio (3Y)	0.6
Sharpe ratio (5Y)	0.27
Sortino ratio	1.29
Sortino ratio (3Y)	0.95
Sortino ratio (5Y)	0.48
Volume	803.3K
Weekly RSI	52.52
YTD price change	35.21%
YTD total return	35.21%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	74.7M
Float percentage	72.58%
Shares change (QoQ)	75.17%
Shares change (YoY)	82.32%
Shares held by insiders	2.31%
Shares held by institutions	60.73%
Shares outstanding	102.9M
Short % of float	23.4%
Short % of shares	16.98%
Short ratio	10.5 days

Deeper analysis on ACHV

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ACHV report

Is a complete ACHV research report available?

No complete published report is available for Achieve Life Sciences, Inc. (ACHV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Achieve Life Sciences, Inc. (ACHV)

Price

Financial snapshot

Fair-value bridge

Latest news · ACHV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ACHV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ACHV

Frequently asked questions